Developing personalized cancer immunotherapies using microfluidics
Using microfluidics to realize patient-specific anti-cancer immunotherapies
This study is exploring a new way to make cancer treatments more effective by using special technology to create personalized therapies that help your immune cells, called T cells, better fight your cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10931361 on NIH RePORTER |
What this research studies
This research focuses on enhancing cancer treatment by utilizing microfluidic technology to create patient-specific immunotherapies. It aims to improve the activation of T cells, which are crucial for targeting and destroying cancer cells. By analyzing the interactions between T cell receptors and cancer-specific antigens, the research seeks to identify the most effective combinations for each patient. This personalized approach could lead to more effective and tailored cancer treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with various types of cancer who are seeking personalized treatment options.
Not a fit: Patients with non-cancerous conditions or those who do not have a suitable immune response may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide patients with more effective and personalized cancer immunotherapies that specifically target their unique cancer profiles.
How similar studies have performed: Previous research has shown promise in using personalized immunotherapies for cancer treatment, indicating that this approach could lead to significant advancements.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Fordyce, Polly Morrell — Stanford University
- Study coordinator: Fordyce, Polly Morrell
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.